Company News for Feb 24, 2026

By Zacks Equity Research | February 24, 2026, 7:22 AM

Novo Nordisk A/S (NVO) shares fell 16.4% after its obesity drug CagriSema underperformed Eli Lilly and Company (LLY) drug Zepbound in a head-to-head trial.
DoorDash, Inc. (DASH) shares fell 6.6% after halting operations in several locations due to an East Coast blizzard.
PayPal Holdings, Inc. (PYPL) shares rose 5.8% following a Bloomberg report that the payments company is drawing takeover interest.
Veris Residential, Inc. (VRE) shares surged 12.2% after agreeing to be acquired by a consortium led by Affinius Capital for $19 per share in cash.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Novo Nordisk A/S (NVO): Free Stock Analysis Report

Eli Lilly and Company (LLY): Free Stock Analysis Report

PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report

DoorDash, Inc. (DASH): Free Stock Analysis Report

Veris Residential, Inc. (VRE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News

Nov-12	Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020 LLY PR Newswire
Nov-12	GPN Stock On Track For Its Worst Day In About 19 Months As Private Equity Firms Reportedly Abandon Takeover Talks PYPL Stocktwits
Nov-12	Celebrating 20 years of Kiva and PayPal working together to support entrepreneurs worldwide PYPL PR Newswire
Nov-12	Eli Lilly beats Novo to oral China GLP-1RA market on NMPA approval NVO LLY Pharmaceutical Technology
Nov-12	The Stock Market Has Weathered Nvidia's Slide. Jensen Huang's Exit Changes the Equation. LLY Barrons.com
Nov-12	Eli Lilly secures first approval for weight-loss pill in China NVO LLY Proactive
Nov-12	Blackstone backs Pfizers obesity ambitions with $1.5bn fund LLY Pharmaceutical Technology
Nov-12	Novo and DJ Khaled team up to take fans behind the scenes of the iconic musician's real-life "Walk, Golf, and Wegovy" diet and weight-loss routine NVO PR Newswire
Nov-12	Why Pfizer Is Tapping Private Equity to Back Its Once-Monthly Weight-Loss Drug LLY Barrons.com
Nov-12	Beyond GLP-1RAs: Novel mechanisms and combos to shape future of obesity market LLY Pharmaceutical Technology
Nov-12	Beyond GLP-1RAs: Novel mechanisms and combos to shape future of obesity market NVO Pharmaceutical Technology
Nov-12	The world's most sophisticated drug companies are putting billions into vaccines - despite the political environment LLY MarketWatch
Nov-12	Premarket movers: Nvidia sinks; Lilly gains on China approval LLY Investing.com
Nov-12	Eli Lilly Shares Rise 2.8% After China Approves Orforglipron Weight-Loss Pill LLY InvestorsHub
Nov-12	Eli Lilly Shares Rise 2.8% After China Approves Orforglipron Weight-Loss Pill NVO InvestorsHub

Company News for Feb 24, 2026

Mentioned In This Article

Latest News

Upgrade your Finviz experience